Distinct regions of frequent loss of heterozygosity of chromosome 5p and 5q in human esophageal cancer

International Journal of Cancer

Volumn 78, Issue 5, 1998, Pages 600-605

  Peralta, Robert C ^a   Casson, Alan G ^a   Wang, Rui Nan ^b   Keshavjee, Shaf ^c   Redston, Mark ^a   Bapat, Bharati ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHROMOSOME 5P; CHROMOSOME 5Q; CHROMOSOME LOSS; ESOPHAGUS CANCER; GENE LOCUS; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; CARCINOMA, SQUAMOUS CELL; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 5; ESOPHAGEAL NEOPLASMS; HUMANS; LOSS OF HETEROZYGOSITY;

EID: 0031788964     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19981123)78:5<600::AID-IJC12>3.0.CO;2-1     Document Type: Article

References (25)

1. ALKASSPOOLES, M., MOORE, J.H., ORRINGER, M.B. and BEER, D.G., Amplification and overexpression of the egfr and erbB-2 genes in human esophageal adenocarcinomas. Int. J. Cancer, 54, 213-219 (1993).
2. AOKI, T., MORI, T., DU, X., NISIHIRA, T., MATSUBARA, T. and NAKAMURA, Y., Allelotype study of esophageal carcinoma. Genes Chromosomes Cancer, 10, 177-182 (1994).
3. BAPAT, B., MITRI, A. and GREENBERG, C.R., Improved predictive carrier testing for familial adenomatous polyposis using DNA from a single archival specimen and polymorphic markers with multiple alleles. Hum. Pothol., 24, 1376-1379 (1993).
4. BARRETT, M.T., SCHUTTE, M., KERN, S.E. and REID, B.J., Allelic loss and mutational analysis of the dpc4 gene in esophageal adenocarcinoma. Cancer Res., 56, 4351-4353 (1996).
5. BLOUNT, P.L., MELTZER, S.J., YIN, J., HUANG, Y., KRASNA, M.J. and REID, B.J., Clonal ordering of 17p and 5q allelic losses in Barrett's dysplasia and adenocarcinoma. Proc. nat. Acad. Sci. (Wash.), 90, 3221-3225 (1993).
6. BOYNTON, R.F. and 12 OTHERS, Loss of heterozygosity involving the apc and nice genetic loci occurs in the majority of human esophageal cancers. Proc. natl. Acad. Sci. (Wash.), 89, 3385-3388 (1992).
7. CASSON, A.G., MUKHOPADHYAY, T., CLEARY, K.R., RO, J.Y, LEVIN, B. and ROTH, J.A., p53 gene mutations in Barrett's epithelium and esophageal cancer. Cancer Res., 51, 4495-4499 (1991).
8. DING, S.F., HABIB, N.A., DOOLEY, J., WOOD, C., BOWLES, L. and DELHANTY, J.D.A., Loss of constitutional heterozygosity on chromosome 5q in hepatocellular carcinoma without cirrhosis. Brit. J. Cancer, 64, 1083-1087 (1991).
9. HAMMOUD, Z.T., KALEEM, Z., COOPER, J.D., SUNDARESAN, R.S., PATTERSON, G.A. and GOODFELLOW, P.J., Allelotype analysis of esophageal adenocarcinomas: evidence for the involvement of sequences on the long arm of chromosome 4. Cancer Res., 56, 4499-4502 (1996).
10. HOLLSTEIN, M.C., METCALF, R.A., WELSH, J.A., MONTESANO, R. and HARRIS, C.C., Frequent mutation of the p53 gene in human esophageal cancer. Proc. nat. Acad. Sci. (Wash.), 87, 9958-9961 (1990).
11. HUANG, Y., BOYNTON, R.F., BLOUNT, P.L., SILVERSTEIN, R.J., YIN, J., TONG, Y, MCDANIEL, T.K., NEWKIRK, C., RESAU, J.H., SRIDHARA, R., REID, B.J. and MELTZER, S.J., Loss of heterozygosity involves multiple tumor suppressor genes in human esophageal cancers. Cancer Res., 52, 6525- 6530 (1992).
12. JIANG, W., ZHANG, Y.J., KAHN, S.M., HOLLSTEIN, M.C., SANTELLA, R.M., LU, S.H., HARRIS, C.C., MONTESANO, R. and WEINSTEIN, I.B., Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer. Proc. nat. Acad. Sci. (Wash.), 90, 9026-9030 (1993).
13. LASKO, D., CAVENEE, W. and NORDENSKJÖLD, M., Loss of constitutional heterozygosity in human cancer. Ann. Rev. Genet. 25, 281-314 (1991).
14. MAESAWA, C., TAMURA, G., SUZUKI, Y., OGASAWARA, S., ISHIDA, K., SAITO, K. and SATODATE, R., Aberrations of tumor-suppressor genes (p53, ape, mcc, and Rb) in esophageal squamous cell carcinoma. Int. J. Cancer, 57, 21-25 (1994).
15. MITRA, A.B., MURTY, V.V.V.S., LI, R.G., PRATAP, M., LUTHRA, U.K. and CHAGANTI, R.S.K., Allelotype analysis of cervical carcinoma. Cancer Res., 54, 4481-4487 (1994).
16. MIYOSHI, Y., NAGASE, H., ANDO, H., HORII, A., ICHII, S., NAKATSURU, S., AOKI, T., MIKI, Y., MORI, T. and NAKAMURA, Y., Somatic mutations of the ape gene in colorectal tumors: mutation cluster region in the ape gene. Hum. mol. Genet., 1, 229-233 (1992).
17. MONTESANO, R., HOLLSTEIN, M. and HAINAUT, P., Genetic alterations in esophageal cancer and their relevance to etiology and pathogenesis: a review. Int. J. Cancer (Pred. Oncol.), 69, 225-235 (1996).
18. MURTY, V.V.V.S., REUTER, V.E., BOSL, G.J. and CHAGANTI, R.S.K., Deletion mapping identifies loss of heterozygosity at 5p 15.1-15.2, 5q11 and 5q34-35 in human male germ cell tumors. Oncogene, 12, 2719-2723 (1996).
19. OGASAWARA, S., TAMURA, G., MAESAWA, C., SUZUKI, Y., ISHIDA, K., SATOH, N., UESUGI, N., SAITO, K. and SATODATE, R., Common deleted region on the long arm of chromosome 5 in esophageal carcinoma. Gastroenterology, 110, 52-57 (1996).
20. PARKIN, D.M., PISANI, P. and FERLAY, J., Estimates of the worldwide incidence of eighteen major cancers in 1985. Int. J. Cancer, 54, 594-606 (1993).
21. POWELL, S.M., PAPADOPOULOS, N., KINZLER, K.W., SMOLINSKJ, K.N. and MELTZER. S.J., ape gene mutations in the mutation cluster region are rare in esophageal cancers. Gastroenterology, 107, 1759-1763 (1994).
22. SHIBAGAKI, I., SHIMADA, Y., WAGATA, T., IKENAGA, M., IMAMURA, M. and ISHIZAKI, K., Allelotype analysis of esophageal squamous cell carcinoma. Cancer Res., 54, 2996-3000 (1994).
23. WEILAND, I. and BOHM, M., Frequent allelic deletion at a novel locus on chromosome 5 in human lung cancer. Cancer Res., 54, 1772-1774 (1994).
24. WEILAND, I., BOHM, M., ARDEN, K.C., AMMERMULLER, T., BOGATZ, S., VIARS, C.S. and RAJEWSKY, M.F., Allelic deletion mapping on chromosome 5 in human lung carcinomas. Oncogene, 12, 97-102 (1996).
25. WILLMAN, C.L., SEVER, C.E., PALLAVICINI M.G., HARADA, H., TANAKA, N., SLOVAK, M.L., YAMAMOTO, H., HARADA, K., MEEKER, T.C., LIST, A.F. and TANIGUCHI, T., Deletion of irf-1 mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia. Science, 259, 968-971 (1993).